Novel method for preparing important intermediate of minodronate
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 北京京卫信康医药科技发展有限公司
- Publication Date
- 2010-08-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field The invention relates to a preparation method of 2-(imidazo[1,2-a]pyridin-3-yl)acetic acid, which can be used as an intermediate for preparing minodronic acid. Background technique Minodronic acid, the chemical name is 1-hydroxy-2-[(imidazo[1,2-a]pyridin-3-yl)]ethylene-1,1-bisphosphonic acid, developed by Japan Yamanouchi Company The novel heterocyclic bisphosphonic acid compound is used for the treatment of osteoporosis. The results of pharmacological experiments show that the activity of this product in inhibiting bone resorption is disodium incadronate (disodium incadronate), alendronate sodium (alendronate) and 2, 10 and 100 times that of disodium pamidronate. Its chemical structure is as follows: minodronic acid Compound shown in formula (I) is the important intermediate of synthetic minodronic acid, and the synthetic method of minodronic acid is reported in EP0354806 respectively, and its preparation technology is: The preparation process route d...